The RT-qPCR assay results illustrated that both CD81 and CDKN1A were significantly downregulated in the tumor tissue compared adjacent normal tissue (p < 0.0001 of CD81 and p = 0.0029 of CDKN1A, Figure 8). This evidence concerns the gene CD81 and neoplasm.